By
AmyT on
January 26, 2010
When the JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here.
Today, I bring you those answers, direct “from the horses’ mouth,” as it were.
Usage Issues
Q) How much more advanced will this be than the Medtronic Paradigm Veo system launched in Europe, which stops insulin delivery for…
Read more »
By
AmyT on
December 1, 2009
Living in the United States, we are often stuck in a bubble of US-centric news. This is true for diabetes as much as any other topic. But as World Diabetes Day attests to, diabetes is hardly just an American thing. In reality, there’s much more going on in the global diabetes research arena than you might think (since our media announcements are pretty much limited to, err, Boston, Miami and the Bay Area). So today,…
Read more »
By
AmyT on
September 30, 2009
Apropos to last week’s post on Testing Driving Insulin, I was thinking about the ‘older’ versions — and discovered a reader letter I received back in February of 2006. It seems just as timely today, considering that research supported the case for continuing to offer patients the option of animal insulin:
“In our systematic review we could not identify substantial differences in the safety and efficacy between insulin species. Many important patient-oriented outcomes like health-related…
Read more »
By
AmyT on
September 4, 2009
{Editor’s Note: apparently I’m all over Time magazine this week, or it’s all over me…}
Finally, some breakthrough diabetes research that does not only involve mice! Time magazine’s August 31 issue reports on new a stem-cell-based study that involved taking skin cells from two people with type 1 diabetes, exposing the cells to “a cocktail of three genes that converted them back to an embryonic state,” and then “instructing” the cells to grow into beta…
Read more »
By
AmyT on
August 31, 2009
New briefs this week: An Australian company that makes “cosmeceuticals” is developing an insulin gel patch in collaboration with the Joslin Diabetes Center at Harvard Medical School. A Japanese company that makes synthetic fabrics is developing an insulin nasal spray with Hoshi University in Tokyo.
Hey, I don’t make this stuff up. As you well know, these kinds of headlines are either tantalizingly exciting, or disgustingly frustrating, depending on how long you’ve had the ‘betes…
Read more »
